Foresee Pharmaceuticals , Ltd. (6576.TWO) has a profit margin of 4.77%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Foresee Pharmaceuticals , Ltd.'s profit margin stands at 4.77% as of June 2026. That compares with -320.65% in the prior-year period — up 101.5% year over year. That is below the sector sector average of 13.4%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Foresee Pharmaceuticals , Ltd. reported 4.77% in profit margin versus -320.65% a year earlier — a 101.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Foresee Pharmaceuticals , Ltd. sits lower the its sector benchmark (13.4%) with a profit margin of 4.77%. That is roughly 64.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 4.77% for Foresee Pharmaceuticals , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Foresee Pharmaceuticals , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6576.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.